Australian Pharmaceutical Industries Ltd
ASX:API
Australian Pharmaceutical Industries Ltd
Cash from Financing Activities
Australian Pharmaceutical Industries Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Australian Pharmaceutical Industries Ltd
ASX:API
|
Cash from Financing Activities
-AU$36.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Paragon Care Ltd
ASX:PGC
|
Cash from Financing Activities
AU$14.7m
|
CAGR 3-Years
131%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
8%
|
|
Sigma Healthcare Ltd
ASX:SIG
|
Cash from Financing Activities
AU$295.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Cronos Australia Ltd
ASX:CAU
|
Cash from Financing Activities
-AU$6.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Australian Pharmaceutical Industries Ltd's Cash from Financing Activities?
Cash from Financing Activities
-36.8m
AUD
Based on the financial report for Aug 31, 2021, Australian Pharmaceutical Industries Ltd's Cash from Financing Activities amounts to -36.8m AUD.
What is Australian Pharmaceutical Industries Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
13%
Over the last year, the Cash from Financing Activities growth was 85%.